Nuvelus is the first of six new startups that will be launched by postdocs this year
Nuvelus Inc., an innovative biotechnology company that seeks to heal and transform
damaged skin caused by inflammation, disease and environmental stress is dedicated
to building a novel solution to treat the body's largest organ – the skin. Nuvelus
is the first startup to come out of The University of Memphis FedEx Institute of Technology
and Epicenter's joint Patent2Products (P2P) Program and, over the next year, five
more companies will be launched as part of this initiative.
Nuvelus' patent-pending technology utilizes a topical approach to deliver ingredients
required to facilitate healing and rejuvenation of the skin. The technology works
directly on the immune system, the main culprit in recruiting the cellular components
to the site in need of repair. Nuvelus has discovered an intricate link between the
immune system and skin. This allows for the treatment of a wide variety of skin-related
ailments through the application of their product. These conditions include psoriasis,
rosacea, eczema, acne, sunburn, lupus and arthritis.
"We believe improved skincare therapy can promote rapid healing of damaged skin, improving
quality of life, and reducing the anxiety and stress associated from visible marks
on your body and face." says Dr. Ryan Hughes, Founder and CEO of Nuvelus, Inc. "Our
solution supplants the age-old treatment of topical steroids, and replaces it with
a product that is safer, more effective, and better suited to treat unwanted skin
abnormalities. We are a company that believes treating the skin should be more than
just skin deep."
The University of Memphis and Epicenter partnered to create the P2P Program, designed
to hire post-doc fellows to start businesses utilizing patented intellectual property
developed both in Memphis and across the United States, to turn great ideas into successful
companies. The program creates a two-year funded position for research entrepreneurs
and provides them with the necessary tools for launching a successful startup.
"Enabling deep science entrepreneurship is a critical role for research universities," stated Dr. Jasbir Dhaliwal, executive vice president of Research and Innovation. "Dr. Hughes' company shows the promise and potential that UofM technology and research expertise paired with the Memphis' innovator ecosystem could bring to the city."
For more information on this company, visit: www.Nuvelus.com and follow on Twitter: https://twitter.com/Nuvelus_Inc.
For more information on this partnership, contact Mary Ann Dawson at mdawson@memphis.edu, or Jessica Taveau at jessica@epicentermemphis.org.